ENVESTNET ASSET MANAGEMENT INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$345,669
-50.0%
41,348
+48.6%
0.00%
Q2 2023$691,098
+189.9%
27,822
+75.5%
0.00%
Q1 2023$238,369
+92.7%
15,849
+51.6%
0.00%
Q4 2022$123,683
-56.6%
10,455
+21.9%
0.00%
Q3 2021$285,000
-40.9%
8,574
-31.0%
0.00%
Q2 2021$482,000
-8.4%
12,421
+13.9%
0.00%
Q1 2021$526,000
+49.9%
10,908
+61.5%
0.00%
Q4 2020$351,0006,7540.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders